Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.
A wealth of research over the last 30 years has strongly indicated that stroke recovery can be significantly improved through immersive stimulation and robotic assistance.
The Torque3 system leverages this research with an approach of uncompromising design and implementation combining a robotic chair and virtual reality.
In this episode, Founder/CEO David Ellzey shares some of the science behind Torque3 and insights into where they are headed.
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of...
John P. Pigott, MD, FACS, currently serves as Chief Innovations Officer/Strategic Business Development for ProMedica and ProMedica Innovations, where he works with thought leaders...
